Obesity and COVID-19: The Clash of Two Pandemics
Overview
Authors
Affiliations
Current treatment landscape for obesity in Singapore.
Lee P, Lim C, Asokkumar R, Chua M Singapore Med J. 2023; 64(3):172-181.
PMID: 36876623 PMC: 10071854. DOI: 10.4103/singaporemedj.SMJ-2022-216.
High-Dose Liraglutide and SGLT2 Inhibitor: A Promising Combination.
Chua M Clin Pract. 2022; 12(1):1-7.
PMID: 35076486 PMC: 8788265. DOI: 10.3390/clinpract12010001.
Contrasting Narratives of Race and Fatness in Covid-19.
Chellappoo A Hist Philos Life Sci. 2021; 43(4):120.
PMID: 34792657 PMC: 8600351. DOI: 10.1007/s40656-021-00477-5.
Low 25(OH)D Level Is Associated with Severe Course and Poor Prognosis in COVID-19.
Karonova T, Andreeva A, Golovatuk K, Bykova E, Simanenkova A, Vashukova M Nutrients. 2021; 13(9).
PMID: 34578898 PMC: 8468115. DOI: 10.3390/nu13093021.
Chua M Obes Surg. 2021; 32(1):192-193.
PMID: 34322841 PMC: 8318550. DOI: 10.1007/s11695-021-05596-3.